1,070
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Anti-inflammatory activities, triterpenoids, and diarylheptanoids of Alnus acuminata ssp. arguta

, , , , , , & show all
Pages 1052-1057 | Received 12 Jan 2010, Accepted 16 Feb 2011, Published online: 20 May 2011
 

Abstract

Context: The main use of stem bark infusions of Alnus acuminata ssp. arguta (Schlecht.) Furlow (Betulaceae) includes treatments for acute inflammation in Mexican traditional medicine.

Objective: n-Hexane (CHE), chloroform (CCE), and methanol (CME) extracts of the stem bark were investigated for anti-inflammatory activity and its safety.

Materials and methods: The anti-inflammatory effects of the orally administered CME, CCE, and CHE extracts, using carrageenan-induced rat hind paw edema model, and acute oral toxicity in mice, using Lorke’s method, were determined.

Results and discussion: The column chromatographic fraction (CME-3) showed a higher anti-inflammatory activity (92.2%) (IC50: 60.8 mg/mL) as compared with CME (76.9%); both were in the same order of magnitude as that of indomethacin, the positive control drug. Safety parameters for acute oral toxicity test showed that CME was not toxic (LD50: >5000). Several triterpenoids (17) from hexane extracts and diarylheptanoids (1014) from methanol extracts of A. acuminata ssp. arguta were isolated and characterized.

Conclusions: These results confirm the traditional uses of A. acuminata in acute inflammatory conditions and its safety for consumption.

Acknowledgement

The authors wish to thank Dirección General de Asuntos del Personal Académico de la UNAM (DGAPA) for economical support (PAPIIT IN210709 and IN205008), so as to thank A. Acosta, N. Esturau, R.I. del Villar, G. Duarte, M. Guzmán, M. Gutiérrez, and M.Y. González for spectroscopic assistance.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.